scispace - formally typeset
G

Gerd Wallukat

Researcher at Max Delbrück Center for Molecular Medicine

Publications -  252
Citations -  12575

Gerd Wallukat is an academic researcher from Max Delbrück Center for Molecular Medicine. The author has contributed to research in topics: Receptor & Angiotensin II. The author has an hindex of 58, co-authored 241 publications receiving 11402 citations. Previous affiliations of Gerd Wallukat include Humboldt University of Berlin.

Papers
More filters
Journal ArticleDOI

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.

TL;DR: It is suggested that preeclamptic patients develop stimulatory autoantibodies against the second extracellular AT1 receptor loop, which appears to be PKC-mediated and may participate in the angiotensin II-induced vascular lesions in these patients.
Journal ArticleDOI

Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.

TL;DR: A non-HLA, AT1-receptor-mediated pathway may contribute to refractory vascular rejection, and affected patients might benefit from removal of At1- receptor antibodies or from pharmacologic blockade of AT1 receptors.
Journal ArticleDOI

Arachidonic Acid-metabolizing Cytochrome P450 Enzymes Are Targets of ω-3 Fatty Acids

TL;DR: It is found that these ω-3 epoxides are highly active as antiarrhythmic agents, suppressing the Ca2+-induced increased rate of spontaneous beating of neonatal rat cardiomyocytes, at low nanomolar concentrations.
Journal ArticleDOI

Weaning From Mechanical Cardiac Support in Patients With Idiopathic Dilated Cardiomyopathy

TL;DR: In this article, the authors report long-term effects of ventricular unloading on cardiac function, humoral anti-β1-adrenoceptor autoantibodies (A-β 1-AABs), and myocardial fibrosis.
Journal ArticleDOI

Immunoglobulin Adsorption in Patients With Idiopathic Dilated Cardiomyopathy

TL;DR: In IDC, theUse of immunoadsorption is superior to the use of standard medical therapy and significantly improves cardiac performance and clinical status.